2.12
Finanzdaten der Xbiotech Inc-Aktie (XBIT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
6.146
|
- | 6.047 | 6.336 | 13.55 |
| Operating Income/Loss |
2.04%
-6.146
|
-6.274 | -6.047 | -6.336 | -13.55 |
| Nonoperating Income/Loss |
165.53%
-0.536
|
0.818 | 0.141 | 4.608 | 2.695 |
| Income/Loss From Continuing Operations Before Tax |
22.47%
-6.682
|
-5.456 | -5.906 | -1.728 | -10.86 |
| Income Tax Expense/Benefit |
6.12%
0.046
|
0.049 | 0.102 | 0.028 | 0.029 |
| Net Income/Loss |
22.22%
-6.728
|
-5.505 | -6.008 | -1.756 | -10.88 |
| Basic Average Shares |
0.00%
30.49
|
30.49 | 30.49 | 30.49 | 30.49 |
| Basic Earnings Per Share |
22.22%
-0.22
|
-0.18 | -0.20 | -0.06 | -0.36 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):